⌘K

Login Start Free

Home/Filings/4/0001181431-15-003280

4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001181431-15-003280

CIK 0001369786operating

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:11 PM ET

Size

5.8 KB

Accession

0001181431-15-003280

Insider Transaction Report

Form 4

Period: 2015-02-21

Sagent Pharmaceuticals, Inc.SGNT

VP, Sales and Marketing

Transactions

Tax Payment
Common Stock
2015-02-22$28.50/sh−293$8,351→ 24,219 total
Tax Payment
Common Stock
2015-02-21$28.50/sh−449$12,797→ 24,512 total

Documents

1 file

4
rrd422816.xmlPrimary

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001369786

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 6:11 PM ET
Size: 5.8 KB

View on SEC.gov